AI Pharma Innovation Clinical Development 2018 is a conference dedicated to integration & application of AI and machine learning to improve clinical development success towards the development and delivery of effective, value-based & precision medicines to market.
AI Pharma Innovation Clinical Development 2018 covers topics such as:
- Assessing and addressing key challenges and opportunities of real world applications of AI & machine learning in clinical development based on case studies from Merck, Pfizer, GSK & Sanofi
- Understanding how AI & machine learning is disrupting the current approach to clinical development through case studies from GSK, Merck, Sanofi & Abbvie
- Finding out about the most innovative approaches of the large pharma towards precision medicine from leaders from Eli Lilly & Abbvie
- Evaluating the hurdles and the future landscape of AI-driven patient stratification, biomarker identification & optimization of clinical designs based on solution led talks of leading biotechs such as InSilico Medicine, Berg & Lantern Pharma
- Through deep discussions with key decision makers in the industry such as Takeda, Merck, & Sanofi cut through theories and learn about proof of concept of how AI is going to revolutionize traditional pharmaceutical practices
